EpiCor

DIETARY_SUPPLEMENT3 trials

Sponsors

Centre Hospitalier Universitaire de Saint Etienne, ProDigest, Cargill

Conditions

Atrial FibrillationConstipationGastrointestinal DiscomfortMitral ValvulopathySigns and Symptoms, Respiratory

Unknown Phase

Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology or Drug Therapy for Patients With AF Requiring Mitral Valve Surgery

TerminatedNCT01649544

Centre Hospitalier Universitaire de Saint EtienneAtrial Fibrillation, Mitral Valvulopathy

Start: 2012-03-31End: 2015-09-30Updated: 2015-12-02

Clinical Evaluation of the Effects of EpiCor on Digestive Comfort

CompletedNCT03051399

ProDigestConstipation, Gastrointestinal Discomfort

Start: 2015-07-06End: 2016-11-30Updated: 2017-02-14

Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children

CompletedNCT05492370

CargillSigns and Symptoms, Respiratory

Start: 2022-09-07End: 2023-07-19Updated: 2023-11-18

Related Papers

A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial.

2017-09-0430 citations